Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Johnstone

Showing results (301-310 of 600) with videos related to

Pageof 60
Sort By:
Journal of Intellectual Disability Research : JIDR|April 12, 2001
Correlations between clinical and historical variables, and cerebral structural variables in people with mild intellectual disability and schizophreniaT L Sanderson, G A Doody, J Best, et al.
Schizophrenia Research|May 30, 2001
A MRI study of ocular hypertelorism in individuals at high risk of developing schizophreniaJ Boyes, H C Whalley, S M Lawrie, et al.
Pharmacogenetics and Genomics|January 15, 2008
Association of COMT Val108/158Met genotype with smoking cessationMarcus R Munafò, Elaine C Johnstone, Boliang Guo, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 1, 1983
Effects of ECT on pituitary hormone release: relationship to seizure, clinical variables and outcomeJ F Deakin, I N Ferrier, T J Crow, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 2, 2010
Duration of untreated illness and outcome in schizophrenia: test of predictions in relation to relapse riskDavid Cunningham Owens, Eve C Johnstone, Patrick Miller, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 1, 1981
Platelet monoamine oxidase activity in acute schizophrenia: relationship to symptomatology and neuroleptic medicationF Owen, R C Bourne, T J Crow, et al.
Archives of General Psychiatry|November 1, 1987
White matter reduction in the parahippocampal gyrus of patients with schizophreniaN Colter, S Battal, T J Crow, et al.
Angewandte Chemie (International Ed. in English)|July 26, 2022
Biomimetic Total Synthesis and Investigation of the Non-Enzymatic Chemistry of Oxazinin AVictor Aniebok, Rahul D Shingare, Hsiau Wei-Lee, et al.
Medical Devices (Auckland, N.Z.)|September 26, 2015
Acceptability of the reusable SurePal™ self-injection device for Omnitrope(®) among pediatric patients: results from a questionnaire-based, cross-sectional, multicenter observational studyCarl-Joachim Partsch, Dirk Schnabel, Sarah Ehtisham, et al.
Dalton Transactions (Cambridge, England : 2003)|February 18, 2026
Inhibition of PHPT1 by phenylarsonic acidsE Dalles Keyes, Sophia E Hollow, Paul Oblad, et al.
Pageof 60

Showing results (301-310 of 600) with videos related to

Sort By:
Pageof 60
Journal of Intellectual Disability Research : JIDR|April 12, 2001
Correlations between clinical and historical variables, and cerebral structural variables in people with mild intellectual disability and schizophreniaT L Sanderson, G A Doody, J Best, et al.
Schizophrenia Research|May 30, 2001
A MRI study of ocular hypertelorism in individuals at high risk of developing schizophreniaJ Boyes, H C Whalley, S M Lawrie, et al.
Pharmacogenetics and Genomics|January 15, 2008
Association of COMT Val108/158Met genotype with smoking cessationMarcus R Munafò, Elaine C Johnstone, Boliang Guo, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 1, 1983
Effects of ECT on pituitary hormone release: relationship to seizure, clinical variables and outcomeJ F Deakin, I N Ferrier, T J Crow, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 2, 2010
Duration of untreated illness and outcome in schizophrenia: test of predictions in relation to relapse riskDavid Cunningham Owens, Eve C Johnstone, Patrick Miller, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 1, 1981
Platelet monoamine oxidase activity in acute schizophrenia: relationship to symptomatology and neuroleptic medicationF Owen, R C Bourne, T J Crow, et al.
Archives of General Psychiatry|November 1, 1987
White matter reduction in the parahippocampal gyrus of patients with schizophreniaN Colter, S Battal, T J Crow, et al.
Angewandte Chemie (International Ed. in English)|July 26, 2022
Biomimetic Total Synthesis and Investigation of the Non-Enzymatic Chemistry of Oxazinin AVictor Aniebok, Rahul D Shingare, Hsiau Wei-Lee, et al.
Medical Devices (Auckland, N.Z.)|September 26, 2015
Acceptability of the reusable SurePal™ self-injection device for Omnitrope(®) among pediatric patients: results from a questionnaire-based, cross-sectional, multicenter observational studyCarl-Joachim Partsch, Dirk Schnabel, Sarah Ehtisham, et al.
Dalton Transactions (Cambridge, England : 2003)|February 18, 2026
Inhibition of PHPT1 by phenylarsonic acidsE Dalles Keyes, Sophia E Hollow, Paul Oblad, et al.
Pageof 60